1. Home
  2. KTTA vs EBON Comparison

KTTA vs EBON Comparison

Compare KTTA & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.60

Market Cap

23.2M

Sector

Health Care

ML Signal

HOLD

Logo Ebang International Holdings Inc.

EBON

Ebang International Holdings Inc.

N/A

Current Price

$2.10

Market Cap

19.5M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
KTTA
EBON
Founded
2020
2010
Country
United States
China
Employees
5
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
23.2M
19.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KTTA
EBON
Price
$0.60
$2.10
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
375.1K
2.9K
Earning Date
05-14-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$1.61
52 Week High
$2.06
$5.90

Technical Indicators

Market Signals
Indicator
KTTA
EBON
Relative Strength Index (RSI) 28.55 48.17
Support Level $0.54 $1.80
Resistance Level $0.85 $2.33
Average True Range (ATR) 0.05 0.11
MACD -0.01 0.01
Stochastic Oscillator 11.07 60.11

Price Performance

Historical Comparison
KTTA
EBON

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.

Share on Social Networks: